![](/accounts/issx/images/logo.png)
![](https://0285ccf8d8d5a9b20200-3e169e2c0ff5fc72cbbca6def6c650ae.ssl.cf2.rackcdn.com/issx_e0a4f149d8eafa55c683a7f70141d9eb.png)
Webinars
-
Contains 3 Component(s) Includes a Live Web Event on 09/24/2024 at 10:45 AM (EDT)
The purpose of this webinar is to: 1. Provide valuable knowledge exchange between ADC developers andthe Regulatory Agency (FDA) 2. Hear from leading experts in PK/PD, pharmacometrics, & clinical pharmacology, plus clinicians and regulatory minds, fostering collaborations and partnerships that can propel ADC projects seamlessly. 2. Demonstrate the successful integration of pharmacokinetics and pharmacometrics in ADC clinical development, enhancing your ability to apply these principles to your own work
-
Register
- Non-member - $49
- Member - Free!
- Student - Free!
- More Information
-
Register
-
Contains 3 Component(s)
This webinar is intended to provide education and updates of this evolving area to scientists and graduate students.
-
Register
- Non-member - $49
- Member - Free!
- Student - Free!
- More Information
-
Register
-
Contains 3 Component(s)
This webinar is intended to educate on emerging knowledge on transporter activity modulation in disease state like liver Cirrhosis/hepatic impairment, and its implications on PK in specific populations.
-
Register
- Non-member - $49
- Member - Free!
- Student - Free!
- More Information
-
Register
-
Contains 3 Component(s)
Attendees will be educated on utility of mathematical models to characterize ADME of TPs. Emerging modeling approaches will be introduced and recent case examples will be discussed.
-
Register
- Non-member - $49
- Member - Free!
- Student - Free!
- More Information
-
Register
-
Contains 3 Component(s)
By understanding the relationship between biomarkers (e.g., antibody titers) and efficacy in preclinical species, how this translates to the clinic, to inform humoral and cell responses needed for protection will allow for adequate understanding of clinical effects in special populations, posology for new variants, and the potential for drug interactions. Together, these data-driven approaches should be embraced to accelerate the delivery of safe and efficacious vaccines to patients globally.
-
Register
- Non-member - $49
- Member - Free!
- Student - Free!
- More Information
-
Register
Events
-
Contains 6 Component(s)
This course was developed by the ISSX Modeling and Simulation Focus Group and will be moderated by Maria Posada, Ph.D., Eli Lilly and Company, USA, Oliver Hatley, Ph.D., Certara UK, United Kingdom, and Jaydeep Yadav, Ph.D. Merck, USA. This short course will focus on the fundamentals of modeling and simulation, spanning several modeling disciplines, including PBPK, QSP, PopPK and Biopharmaceutics, (small molecules, peptides, proteins, or new modalities). The course will include the fundamentals for beginners, advancement, and application, as well as case examples.
-
Register
- Non-member - $300
- Member - $200
- Student - $75
- More Information
-
Register
-
Contains 3 Product(s)
This virtual workshop will focus on the advancements in the application of PBPK as a mechanistic tool in the discovery and development setting. The workshop has been structured into three sessions with emphasis on emerging trends such as special population, biomarker-informed DDI modeling, and diverse drug development applications. Each session will include lectures and short presentations, the latter will be selected from the pool of abstracts from the students and industry attendees. The workshop includes access to all presentation slides and recordings.
-
Register
- Non-member - $400
- Member - $300
- Student - $125
- More Information
-
Register
Access Date | Quiz Result | Score | Actions |
---|